HOME
ABOUT MORSE
The Team
Careers
SERVICES
Our Services
Strategic Advice
MORSE pCPA Assessment
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
RWE/Innovative Agreements
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report
Health Canada Priority Review & Project Orbis Sub-Report
Drugs for Rare Diseases Sub-Report
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Careers
SERVICES
Our Services
Strategic Advice
MORSE pCPA Assessment
MORSE HTA Strategic Advice
Analyses
Advisory Boards
MORSE Advisory Panel (MAP)
Training
RWE/Innovative Agreements
Private Payer
Negotiation Simulation
Reimbursement Training
Reports
Canadian Reimbursement and Forecasting Timelines Report
Health Canada Priority Review & Project Orbis Sub-Report
Drugs for Rare Diseases Sub-Report
Oncology and Biosimilar Sub-Report
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
LINKS
CONTACT US
Private Payers (Desjardins)
September 25, 2017
-
-
Posted by
MORSE
-
< 1
min read.
← PREVIOUS POST
Private Payers (ESI)
NEXT POST →
Private Payers (Blue Cross)
Private Payers (Desjardins) - MORSE Consulting Inc.